BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21182899)

  • 21. Inhibition of the MEK/ERK pathway reduces microglial activation and interleukin-1-beta expression in spinal cord ischemia/reperfusion injury in rats.
    Lu K; Cho CL; Liang CL; Chen SD; Liliang PC; Wang SY; Chen HJ
    J Thorac Cardiovasc Surg; 2007 Apr; 133(4):934-41. PubMed ID: 17382630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of interleukin-17 in ischemic brain tissue.
    Li GZ; Zhong D; Yang LM; Sun B; Zhong ZH; Yin YH; Cheng J; Yan BB; Li HL
    Scand J Immunol; 2005 Nov; 62(5):481-6. PubMed ID: 16305645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aprotinin improves kidney function and decreases tubular cell apoptosis and proapoptotic signaling after renal ischemia-reperfusion.
    Kher A; Meldrum KK; Hile KL; Wang M; Tsai BM; Turrentine MW; Brown JW; Meldrum DR
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):662-9. PubMed ID: 16153910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.
    Khan M; Sekhon B; Jatana M; Giri S; Gilg AG; Sekhon C; Singh I; Singh AK
    J Neurosci Res; 2004 May; 76(4):519-27. PubMed ID: 15114624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat.
    Davies CA; Loddick SA; Toulmond S; Stroemer RP; Hunt J; Rothwell NJ
    J Cereb Blood Flow Metab; 1999 Jan; 19(1):87-98. PubMed ID: 9886359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Netrin-1 regulates Th1/Th2/Th17 cytokine production and inflammation through UNC5B receptor and protects kidney against ischemia-reperfusion injury.
    Tadagavadi RK; Wang W; Ramesh G
    J Immunol; 2010 Sep; 185(6):3750-8. PubMed ID: 20693423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
    Zawadzka M; Kaminska B
    Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop.
    Wenink MH; Santegoets KC; Broen JC; van Bon L; Abdollahi-Roodsaz S; Popa C; Huijbens R; Remijn T; Lubberts E; van Riel PL; van den Berg WB; Radstake TR
    J Immunol; 2009 Dec; 183(11):6960-70. PubMed ID: 19915052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemic brain injury: a consortium analysis of key factors involved in mesenchymal stem cell-mediated inflammatory reduction.
    McGuckin CP; Jurga M; Miller AM; Sarnowska A; Wiedner M; Boyle NT; Lynch MA; Jablonska A; Drela K; Lukomska B; Domanska-Janik K; Kenner L; Moriggl R; Degoul O; Perruisseau-Carrier C; Forraz N
    Arch Biochem Biophys; 2013 Jun; 534(1-2):88-97. PubMed ID: 23466243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lesional expression of EMAPII in macrophages/microglia following cerebral ischemia in rats.
    Liao Y; Zhang Z; Liu J; Schluesener HJ; Zhang Z; Wu Y
    Int J Neurosci; 2011 Feb; 121(2):58-64. PubMed ID: 21047177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation by GD3 of the proinflammatory response of microglia mediated by interleukin-15.
    Gómez-Nicola D; Doncel-Pérez E; Nieto-Sampedro M
    J Neurosci Res; 2006 Apr; 83(5):754-62. PubMed ID: 16477650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of proinflammatory cytokines in lung ischemia-reperfusion injury.
    Krishnadasan B; Naidu BV; Byrne K; Fraga C; Verrier ED; Mulligan MS
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):261-72. PubMed ID: 12579094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Norepinephrine protects cortical neurons against microglial-induced cell death.
    Madrigal JL; Feinstein DL; Dello Russo C
    J Neurosci Res; 2005 Aug; 81(3):390-6. PubMed ID: 15948176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD93/AA4.1: a novel regulator of inflammation in murine focal cerebral ischemia.
    Harhausen D; Prinz V; Ziegler G; Gertz K; Endres M; Lehrach H; Gasque P; Botto M; Stahel PF; Dirnagl U; Nietfeld W; Trendelenburg G
    J Immunol; 2010 Jun; 184(11):6407-17. PubMed ID: 20439917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation.
    Hou YC; Liou KT; Chern CM; Wang YH; Liao JF; Chang S; Chou YH; Shen YC
    Phytomedicine; 2010 Oct; 17(12):963-73. PubMed ID: 20833521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paeonol reduced cerebral infarction involving the superoxide anion and microglia activation in ischemia-reperfusion injured rats.
    Hsieh CL; Cheng CY; Tsai TH; Lin IH; Liu CH; Chiang SY; Lin JG; Lao CJ; Tang NY
    J Ethnopharmacol; 2006 Jun; 106(2):208-15. PubMed ID: 16458462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kainic acid-activated microglia mediate increased excitability of rat hippocampal neurons in vitro and in vivo: crucial role of interleukin-1beta.
    Zheng H; Zhu W; Zhao H; Wang X; Wang W; Li Z
    Neuroimmunomodulation; 2010; 17(1):31-8. PubMed ID: 19816055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-17 potentiates neuronal injury induced by oxygen-glucose deprivation and affects neuronal IL-17 receptor expression.
    Wang DD; Zhao YF; Wang GY; Sun B; Kong QF; Zhao K; Zhang Y; Wang JH; Liu YM; Mu LL; Wang DS; Li HL
    J Neuroimmunol; 2009 Jul; 212(1-2):17-25. PubMed ID: 19457561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated neuronal α-synuclein promotes microglia activation after spinal cord ischemic/reperfused injury.
    Qiao H; Zhang Q; Yuan H; Li Y; Wang D; Wang R; He X
    Neuroreport; 2015 Aug; 26(11):656-61. PubMed ID: 26103121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
    Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
    Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.